Thunen Shelley B's Form 4 filing
RxSight, Inc.RXST · filed Feb 7, 2024
- Accession no.
- 0000950170-24-012317
- Filed
- Feb 7, 2024
- Trade date
- Feb 5-6, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.18M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Thunen Shelley BCIK 0001297491 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 5, 2024 | Common Stock | MOption exerciseAcquired | +6,900 | $4.34 | +$29,946 | 13,691 | Direct | |
| Feb 5, 2024 | Common Stock | MOption exerciseAcquired | +9,125 | $14.95 | +$136,418.75 | 22,816 | Direct | |
| Feb 5, 2024 | Common Stock | SSaleDisposed | −9,125 | $47.02F1 | −$429,057.5 | 13,691 | Direct | |
| Feb 6, 2024 | Common Stock | MOption exerciseAcquired | +15,875 | $14.95 | +$237,331.25 | 29,566 | Direct | |
| Feb 6, 2024 | Common Stock | SSaleDisposed | −15,875 | $47.47F2 | −$753,586.25 | 13,691 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 5, 2024 | Common Stock | MOption exerciseDisposed | −6,900 | $0.00 | $0 | 17,640 | Direct | |
| Feb 5, 2024 | Common Stock | MOption exerciseDisposed | −9,125 | $0.00 | $0 | 110,875 | Direct | |
| Feb 6, 2024 | Common Stock | MOption exerciseDisposed | −15,875 | $0.00 | $0 | 95,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents the weighted average share price of an aggregate total of 9,125 shares sold in the price range of $47.00 to $47.24 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F2
Represents the weighted average share price of an aggregate total of 15,875 shares sold in the price range of $47.16 to $47.77 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.